SEC Form D private-offering filing

Aeovian Pharmaceuticals, Inc.

Name: Aeovian Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Berkeley, CA
Published: 2025-12-22

A new SEC Form D private-offering notice from Berkeley, CA, a $54,999,996 filer-stated offering target in Biotech. The source filing is one click away.

Aeovian Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing a selective mTORC1 inhibitor for tuberous sclerosis complex related epilepsy

Filed 2025-12-22Filed to raise $54,999,996First money in 2025-11-18Raised so far $54,999,996HQ (as filed) Berkeley, CASector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified aeovian.com↗Named in the filing 11 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.